Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/15321
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12973]
Metadata
Show full item record
PREVALENCE OF ESOPHAGEAL ATRESIA AMONG 18 INTERNATIONAL BIRTH DEFECTS SURVEILLANCE PROGRAMS
Author
Nassar, Natasha
Leoncini, Emanuele
Amar, Emmanuelle
Arteaga-Vázquez, Jazmín
Bakker, Marian K.
Bower, Carol
Canfield, Mark A.
Castilla, Eduardo E.
Cocchi, Guido
Correa, Adolfo
Csáky-Szunyogh, Melinda
Feldkamp, Marcia L.
Khoshnood, Babak
Landau, Danielle
Lelong, Nathalie
López-Camelo, Jorge S.
Lowry, R Brian
McDonnell, Robert
Merlob, Paul
Métneki, Julia
Morgan, Margery
Mutchinick, Osvaldo M.
Palmer, Miland N.
Rissmann, Anke
Siffel, Csaba
Sìpek, Antonin
Szabova, Elena
Tucker, David
Mastroiacovo, Pierpaolo
Leoncini, Emanuele
Amar, Emmanuelle
Arteaga-Vázquez, Jazmín
Bakker, Marian K.
Bower, Carol
Canfield, Mark A.
Castilla, Eduardo E.
Cocchi, Guido
Correa, Adolfo
Csáky-Szunyogh, Melinda
Feldkamp, Marcia L.
Khoshnood, Babak
Landau, Danielle
Lelong, Nathalie
López-Camelo, Jorge S.
Lowry, R Brian
McDonnell, Robert
Merlob, Paul
Métneki, Julia
Morgan, Margery
Mutchinick, Osvaldo M.
Palmer, Miland N.
Rissmann, Anke
Siffel, Csaba
Sìpek, Antonin
Szabova, Elena
Tucker, David
Mastroiacovo, Pierpaolo
Affilliation
University of Sydney. Kolling Institute of Medical Research. Population Perinatal Health Research. Sidney, Australia.
Center of the International Clearinghouse for Birth Defects Surveillance and Research. Rome, Italy.
Rhone-Alps Registry of Birth Defects REMERA. Lyon, France.
Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”. Departamento de Genética, Registro y Vigilancia Epidemiológica de Malformaciones Congénitas. Mexico City, Mexico.
5EUROCAT Northern Netherlands. Department of Genetics. University of Groningen. University Medical Center Groningen. Groningen, The Netherlands.
Western Australian Register of Developmental Anomalies. Perth, Australia.
Texas Department of State Health Services. Birth Defects Epidemiology and Surveillance Branch. Austin, TX, USA.
Instituto Nacional de Genética Médica Populacional. Rio de Janeiro, Brasil / Estudio Colaborativo Latino Americano de Malformaciones Congenitas at Centro de Educación Médica e Investigación Clínica. Buenos Aires, Argentina / Estudio Colaborativo Latino Americano de Malformaciones Congenitas at Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Epidemiologia de Malformações Congênitas. Rio de Janeiro, RJ, Brasil.
Bologna University. Department of Pediatrics. Indagine Malformazioni congenite Emilia Romagna Registry.Bologna, Italy.
Centers for Disease Control and Prevention. Metropolitan Atlanta Congenital Defects Program. Division of Birth Defects and Developmental Disabilities. Atlanta, Georgia, USA / University of Mississippi Medical Center, Department of Medicine, Jackson, Mississippi, USA.
National Center for Healthcare Audit and Inspection. Department of Hungarian Congenital Abnormality Registry and Surveillance. Budapest, Hungary.
University of Utah Health Sciences Center. Division of Medical Genetics. Salt Lake City, Utah, USA / Utah Department of Health. Utah Birth Defect Network. Salt Lake City, Utah, USA.
Institut National de la Santé et de la Recherche Médicale. Unité Mixte de Recherche S953. Epidemiological Research on Perinatal Health and Women’s and Children’s Health. Hôpital Cochin and UPMC University. Paris, France.
Soroka University Medical Center. Department of Neonatology. Beer-Sheba, Israel.
Institut National de la Santé et de la Recherche Médicale. Unité Mixte de Recherche S953. Epidemiological Research on Perinatal Health and Women’s and Children’s Health. Hôpital Cochin and UPMC University. Paris, France.
Instituto Nacional de Genética Médica Populacional, Rio de Janeiro, RJ, Brasil / Estudio Colaborativo Latino Americano de Malformaciones Congenitas at Centro de Educación Médica e Investigación Clínica, Buenos Aires, Argentina.
Alberta Health and Wellness. Alberta Congenital Anomalies Surveillance System. Calgary, Canada.
Dublin EUROCAT Registry. Health Service Executive. Dublin, Ireland.
Rabin Medical Center. Department of Neonatology. Beilinson Campus, Petah Tikva, Israel.
National Center for Healthcare Audit and Inspection. Department of Hungarian Congenital Abnormality Registry and Surveillance. Budapest, Hungary.
Singleton Hospital. Congenital Anomaly Register for Wales. Wales, United Kingdom.
Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”. Departamento de Genética, Registro y Vigilancia Epidemiológica de Malformaciones Congénitas. Mexico City, Mexico.
Utah Department of Health. Utah Birth Defect Network, Salt Lake City, Utah, USA.
Otto-von-Guericke University. Malformation Monitoring Centre Saxony-Anhalt. Magdeburg, Germany.
Centers for Disease Control and Prevention. Metropolitan Atlanta Congenital Defects Program. Division of Birth Defects and Developmental Disabilities. Atlanta, Georgia, USA.
Thomayer University Hospital. Department of Medical Genetics. National Registry of Congenital Anomalies of the Czech Republic. Prague, Czech Republic.
Slovak Medical University. Slovak Teratologic Information Centre. Bratislava, Slovak Republic.
Singleton Hospital. Congenital Anomaly Register for Wales. Wales, United Kingdom.
Center of the International Clearinghouse for Birth Defects Surveillance and Research. Rome, Italy.
Center of the International Clearinghouse for Birth Defects Surveillance and Research. Rome, Italy.
Rhone-Alps Registry of Birth Defects REMERA. Lyon, France.
Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”. Departamento de Genética, Registro y Vigilancia Epidemiológica de Malformaciones Congénitas. Mexico City, Mexico.
5EUROCAT Northern Netherlands. Department of Genetics. University of Groningen. University Medical Center Groningen. Groningen, The Netherlands.
Western Australian Register of Developmental Anomalies. Perth, Australia.
Texas Department of State Health Services. Birth Defects Epidemiology and Surveillance Branch. Austin, TX, USA.
Instituto Nacional de Genética Médica Populacional. Rio de Janeiro, Brasil / Estudio Colaborativo Latino Americano de Malformaciones Congenitas at Centro de Educación Médica e Investigación Clínica. Buenos Aires, Argentina / Estudio Colaborativo Latino Americano de Malformaciones Congenitas at Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Epidemiologia de Malformações Congênitas. Rio de Janeiro, RJ, Brasil.
Bologna University. Department of Pediatrics. Indagine Malformazioni congenite Emilia Romagna Registry.Bologna, Italy.
Centers for Disease Control and Prevention. Metropolitan Atlanta Congenital Defects Program. Division of Birth Defects and Developmental Disabilities. Atlanta, Georgia, USA / University of Mississippi Medical Center, Department of Medicine, Jackson, Mississippi, USA.
National Center for Healthcare Audit and Inspection. Department of Hungarian Congenital Abnormality Registry and Surveillance. Budapest, Hungary.
University of Utah Health Sciences Center. Division of Medical Genetics. Salt Lake City, Utah, USA / Utah Department of Health. Utah Birth Defect Network. Salt Lake City, Utah, USA.
Institut National de la Santé et de la Recherche Médicale. Unité Mixte de Recherche S953. Epidemiological Research on Perinatal Health and Women’s and Children’s Health. Hôpital Cochin and UPMC University. Paris, France.
Soroka University Medical Center. Department of Neonatology. Beer-Sheba, Israel.
Institut National de la Santé et de la Recherche Médicale. Unité Mixte de Recherche S953. Epidemiological Research on Perinatal Health and Women’s and Children’s Health. Hôpital Cochin and UPMC University. Paris, France.
Instituto Nacional de Genética Médica Populacional, Rio de Janeiro, RJ, Brasil / Estudio Colaborativo Latino Americano de Malformaciones Congenitas at Centro de Educación Médica e Investigación Clínica, Buenos Aires, Argentina.
Alberta Health and Wellness. Alberta Congenital Anomalies Surveillance System. Calgary, Canada.
Dublin EUROCAT Registry. Health Service Executive. Dublin, Ireland.
Rabin Medical Center. Department of Neonatology. Beilinson Campus, Petah Tikva, Israel.
National Center for Healthcare Audit and Inspection. Department of Hungarian Congenital Abnormality Registry and Surveillance. Budapest, Hungary.
Singleton Hospital. Congenital Anomaly Register for Wales. Wales, United Kingdom.
Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”. Departamento de Genética, Registro y Vigilancia Epidemiológica de Malformaciones Congénitas. Mexico City, Mexico.
Utah Department of Health. Utah Birth Defect Network, Salt Lake City, Utah, USA.
Otto-von-Guericke University. Malformation Monitoring Centre Saxony-Anhalt. Magdeburg, Germany.
Centers for Disease Control and Prevention. Metropolitan Atlanta Congenital Defects Program. Division of Birth Defects and Developmental Disabilities. Atlanta, Georgia, USA.
Thomayer University Hospital. Department of Medical Genetics. National Registry of Congenital Anomalies of the Czech Republic. Prague, Czech Republic.
Slovak Medical University. Slovak Teratologic Information Centre. Bratislava, Slovak Republic.
Singleton Hospital. Congenital Anomaly Register for Wales. Wales, United Kingdom.
Center of the International Clearinghouse for Birth Defects Surveillance and Research. Rome, Italy.
Abstract
BACKGROUND—The prevalence of esophageal atresia (EA) has been shown to vary across
different geographical settings. Investigation of geographical differences may provide an insight
into the underlying etiology of EA.
METHODS—The study population comprised infants diagnosed with EA during 1998 to 2007
from 18 of the 46 birth defects surveillance programs, members of the International Clearinghouse
for Birth Defects Surveillance and Research. Total prevalence per 10,000 births for EA was
defined as the total number of cases in live births, stillbirths, and elective termination of pregnancy
for fetal anomaly (ETOPFA) divided by the total number of all births in the population.
RESULTS—Among the participating programs, a total of 2943 cases of EA were diagnosed with
an average prevalence of 2.44 (95% confidence interval [CI], 2.35–2.53) per 10,000 births,
ranging between 1.77 and 3.68 per 10,000 births. Of all infants diagnosed with EA, 2761 (93.8%)
were live births, 82 (2.8%) stillbirths, 89 (3.0%) ETOPFA, and 11 (0.4%) had unknown outcomes.
The majority of cases (2020, 68.6%), had a reported EA with fistula, 749 (25.5%) were without
fistula, and 174 (5.9%) were registered with an unspecified code.
CONCLUSIONS—On average, EA affected 1 in 4099 births (95% CI, 1 in 3954–4251 births)
with prevalence varying across different geographical settings, but relatively consistent over time
and comparable between surveillance programs. Findings suggest that differences in the
prevalence observed among programs are likely to be attributable to variability in population
ethnic compositions or issues in reporting or registration procedures of EA, rather than a real risk
occurrence difference.
Share